Toulouse Cedex 9

• Clinical study to check the Efficacy and Safety of Mitapivat in Patients with Sickle Cell Disease Pending
  2024-515202-84-00 10 Anemia in subjects with sickle cell disease (SCD)
• Evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendoc … Pending
  2024-515603-19-01 4 Localized digestive Neuroendocrine Carcinomas
• Evaluation of Glucocorticoids Plus Rituximab Compared to Glucocorticoids Plus Placebo for the Treatment of Patients With Newly-Diagnosed or … Pending
  2024-516052-17-01 10 Patients with a diagnosis of IgAV according to Chapel Hill Consensus C
• BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending
  2024-516115-24-00 9 High risk relapsed neuroblastoma (relapsed or progressed after being d
• A multi-center open-label phase 2 study of Ixazomib, Iberdomide and dexamethasone in elderly patients with multiple myeloma at first relapse Pending
  2024-516257-44-00 4 Multiple myeloma
• A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APP … Pending
  2024-516570-30-00 4 Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
• Phase 1/2 evaluating the addition of venetoclax to standard 3+7 and midostaurin induction treatment in patients with FLT3-mutated Acute Myel … Pending
  2024-517130-17-00 9 FLT3-mutated Acute Myeloid Leukemia
• A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti_Tumor Activity of AVZO-02 … Pending
  2024-517339-30-00 7 Advanced Solid Tumors
• Evaluation of Botulinum TOXin type A in the treatment of Buerger’s disease Pending
  2024-517772-38-00 10 Buerger's disease
• A phase IIb, randomized, double-blind, multicenter study evaluating the efficacy of botulinum toxin versus placebo on pain and health relate … Pending
  2024-517948-66-00 4 Piriformis muscle syndrome
• Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter ran … Pending
  2024-518018-22-00 5 staphylococcal endocarditis
• Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and /​ or MSI mCRC. (NIPISAFE) Pending
  2024-518138-10-00 4 Patients with DMMR and/or MSI metastatic colorectal cancer
• A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies Pending
  2024-518326-32-00 7 Patients with advanced solid malignancies that have progressed followi
• Lidocaine for opioid sparing in vaso-occlusive crisis of Sickle Cell Disease Pending
  2024-518437-28-00 5 Sickle cell disease
• Efficacy and safety of allogenic cultured Adipose-derived mesenchymal stromal cell injections on MoUth fibrosis and handicap in patients wit … Pending
  2024-518516-39-00 4 Systemic sclEroderma
• A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older with Locally Advanced or Metastatic … Pending
  2024-518871-74-00 4 Locally Advanced or Metastatic Solid Tumours that harbour MET Amplific
• Efficacy and safety of circumcision alone on risk of febrile urinary tract infections in boys with posterior urethral valves: a prospective … Pending
  2024-519166-48-01 4 Posterior Urethral Valves
• Efficacy of non operative treatment with amoxicillin/clavulanic acid versus surgical treatment in acute uncomplicated appendicitis in childr … Pending
  2024-519402-12-00 5 uncomplicated appendicitis
• A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending
  2024-519504-27-00 5 Relapsed Refractory Multiple Myeloma
• Tucatinib and trastuzumab in HER3-mutant and HER2-not amplified metastatic breast cancer Pending
  2024-519624-24-00 4 HER3-mutant and HER2-not amplified metastatic breast cancer
• PRODIGE 104 – NEOPREDICT A multicenter phase II trial using transcriptomic signatures to personalize neoadjuvant chemotherapy for patients … Pending
  2024-519753-11-00 4 Resectable borderline pancreatic adenocarcinoma
• Open-label Extension of KarXT + KarX-EC for Agitation in Alzheimer’s Disease Pending
  2024-519994-20-00 5 Agitation Associated with Alzheimer’s Disease
• mRNA Therapy to restore lymphatic flow in secondary lymphedema Pending
  2024-520149-22-00 7 Lymphedema
• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease

Showing 25–48 of 893 trials